Amici Capital’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-50,000
Closed -$198K 11
2016
Q4
$198K Buy
+50,000
New +$366K 0.08% 56
2016
Q3
Sell
-100,000
Closed -$1.46M 98
2016
Q2
$1.46M Sell
100,000
-200,000
-67% -$3.42M 0.27% 70
2016
Q1
$5.77M Buy
+300,000
New +$6.06M 0.68% 38
2015
Q2
Sell
-10,300
Closed -$231K 144
2015
Q1
$231K Sell
10,300
-292,100
-97% -$5.6M 0.01% 118
2014
Q4
$5.1M Buy
302,400
+292,400
+2,924% +$4.45M 0.23% 67
2014
Q3
$143K Buy
+10,000
New +$144K ﹤0.01% 144

Other funds holding DVAX

Amici Capital's DVAX Position: Q1 2017 in Review

Amici Capital sold out of Dynavax Technologies (DVAX) in Q1 2017, closing a stake of 100,000 shares — an estimated $395K sold.

Amici Capital first reported a position in DVAX in Q2 2013 and held it in 15 quarters. The position peaked at $60.2M in Q2 2015. 101 funds tracked by Wall St. Rank hold DVAX as of Q1 2017.

  • Amici Capital reported no remaining Dynavax Technologies position as of Q1 2017 after selling out during the quarter.
  • Amici Capital sold 100,000 Dynavax Technologies shares in Q1 2017, an estimated $395K.
  • Amici Capital first reported a position in Dynavax Technologies in Q2 2013 and held it in 15 quarters.
  • Amici Capital's Dynavax Technologies position peaked at $60.2M in Q2 2015.
  • 101 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2017.

Based on Amici Capital's 13F filing for Q1 2017.